Evidence map›Paper›PMID 28763860›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2017

[Role of enolase 1 in hepatocellular carcinoma and possible mechanism].

T T Yan, L N Ma, X Luo, Z H Lu, Q Liu, Y H Xu, X L Liu, X C Ding

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. [A preliminary study of serum marker alpha-enolase in the diagnosis of hepatocellular carcinoma].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

T T YanNingxia Medical University, Yinchuan 750004, China.
L N MaDepartment of Infectious Disease, General Hospital of Ningxia Medical University, Yinchuan750004, China.
X LuoDepartment of Infectious Disease, General Hospital of Ningxia Medical University, Yinchuan750004, China.
Z H LuDepartment of Hepatobiliary Surgery, General Hospital of Ningxia Medical University, Yinchuan 750004, China.
Q LiuDepartment of Hepatobiliary Surgery, General Hospital of Ningxia Medical University, Yinchuan 750004, China.
Y H XuDepartment of Pathology, General Hospital of Ningxia Medical University, Yinchuan750004, China.
X L LiuDepartment of Pathology, General Hospital of Ningxia Medical University, Yinchuan750004, China.
X C Ding

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cell MovementHep G2 CellsBiomarkers, TumorCarcinoma, HepatocellularCell Line, TumorCell ProliferationDNA-Binding ProteinsHumansLiver NeoplasmsNeoplasm InvasivenessPhosphopyruvate HydrataseTumor Suppressor ProteinsBiomarkers, TumorDNA-Binding ProteinsENO1 protein, humanPhosphopyruvate HydrataseTumor Suppressor ProteinsCarcinoma, hepatocellularENO1NOTCH

Identifiers

PMID28763860
PMCPMC12677355

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.